What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
H. Barton Grossman mainly investigates Bladder cancer, Surgery, Cancer, Cystectomy and Urology.
H. Barton Grossman combines subjects such as Urinary bladder, Single-nucleotide polymorphism and Prospective cohort study with his study of Bladder cancer.
His Surgery research is multidisciplinary, incorporating perspectives in Carcinoma in situ and Radiology.
His work carried out in the field of Cystectomy brings together such families of science as Carcinoma, Chemotherapy, Small-cell carcinoma, Intensive care medicine and Tumor suppressor gene.
H. Barton Grossman has included themes like Urinary system, Cystoscopy, Cohort and Univariate analysis in his Urology study.
His research in Internal medicine intersects with topics in Gastroenterology and Oncology.
His most cited work include:
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer (1700 citations)
- Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995)) (1460 citations)
- Epidemiology and risk factors of urothelial bladder cancer (1002 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Bladder cancer, Internal medicine, Surgery, Oncology and Cystectomy.
His Bladder cancer research incorporates elements of Pathology, Urinary bladder, Urology and Chemotherapy.
His work in Internal medicine covers topics such as Genotype which are related to areas like Allele.
His biological study deals with issues like Transitional cell carcinoma, which deal with fields such as Carcinoma.
His Oncology study combines topics from a wide range of disciplines, such as Hazard ratio, Metastasis and Immunotherapy.
H. Barton Grossman interconnects Survival rate, Survival analysis, Retrospective cohort study and Lymph node in the investigation of issues within Cystectomy.
He most often published in these fields:
- Bladder cancer (62.47%)
- Internal medicine (38.24%)
- Surgery (26.84%)
What were the highlights of his more recent work (between 2010-2021)?
- Bladder cancer (62.47%)
- Internal medicine (38.24%)
- Cystectomy (23.75%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Bladder cancer, Internal medicine, Cystectomy, Oncology and Urology.
His Bladder cancer study improves the overall literature in Cancer.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Pathology.
His Cystectomy study incorporates themes from Stage, Urinary bladder, Lymph node and Hazard ratio.
His Oncology research is multidisciplinary, relying on both Survival analysis, Retrospective cohort study, MEDLINE and Immunotherapy.
His study in Urology is interdisciplinary in nature, drawing from both Immunology, Confidence interval, Urinary system, Non muscle invasive and Prospective cohort study.
Between 2010 and 2021, his most popular works were:
- Epidemiology and risk factors of urothelial bladder cancer (1002 citations)
- Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data (257 citations)
- Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer (152 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
H. Barton Grossman focuses on Bladder cancer, Internal medicine, Urology, Surgery and Oncology.
H. Barton Grossman works in the field of Bladder cancer, namely Cystectomy.
His studies deal with areas such as Gastroenterology and Endocrinology as well as Internal medicine.
His work focuses on many connections between Urology and other disciplines, such as Immunology, that overlap with his field of interest in Adenoviridae, Predictive value of tests, Genetic enhancement and Efficacy.
In his work, Biomarker and Progression-free survival is strongly intertwined with Cohort, which is a subfield of Surgery.
His Cancer research includes elements of Case-control study and Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
